Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denufosol in Pediatric Cystic Fibrosis
NCT00130182Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of denufosol tetrasodium in cystic fibrosis (CF), sponsored by Merck & Co.. Started Aug 2005; status: completed.
02
Drugs
denufosol tetrasodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00130182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130182.